Press release
Animal Nutrition
February 28, 2023

Evonik to present innovations in sustainable animal nutrition and health at VIV Asia 2023

  • Evonik Animal Nutrition focuses on efficient and sustainable production of animal protein
  • Solutions to improve animal nutrition, health and welfare
  • System solutions and digital tools complement product and service portfolio

Essen, Germany. Evonik will showcase its wide range of innovative solutions for improving animal nutrition and animal health at VIV Asia in Bangkok, Thailand, taking place from March 8-10. All products, services and system solutions serve one goal: to produce animal protein more efficiently and sustainably, while enhancing animal health and welfare.

"To continue to supply a growing world population with healthy, affordable animal protein, production must be made more sustainable," says Dr. Gaetano Blanda, head of Evonik's Animal Nutrition business line. "We are continually working on cutting-edge solutions, leveraging our decades of experience in animal nutrition to help our customers address the challenges of today and tomorrow."

Asia is an important growth market for Evonik Animal Nutrition. Per capita consumption of poultry products is rising steadily in many Asian countries. At the same time, awareness of the environment and resource consumption is growing. "The market is demanding solutions to intensify production in a resource-conserving way," says Noel Kim, head of the Asia region for Evonik Animal Nutrition. "We look forward to showing our contribution to this at VIV Asia."

At Booth 4010 in Challenger Hall 3, the Evonik team will be on hand to discuss an extensive portfolio of feed additives - from amino acids to probiotics to GuanAMINO®. Visitors can also learn more about how to optimize animal feed so it reaches its full potential through Evonik’s analytical services (AMINONIR®), and see a live demonstration of Evonik’s new microdosing system for powdered amino acids (AMINOSys®).

During the trade show visitors will have the opportunity to attend technical seminars detailing Evonik’s new products and services, covering topics such as GuanAMINO®, sustainability in the animal protein industry, the ‘NextGen’ of water-soluble probiotics (Ecobiol® Fizz) and ScreenFloX®, Evonik’s digital service for pathogen monitoring of poultry flocks.

Evonik Animal Nutrition’s management team will also be hosting the ‘Sciencing Event’, which will exclusively focus on how customers in the region can reach their growth and sustainability goals at a time of fragile supply chains. The event will take place in VIV Square, Challenger Hall 3, on March 9.

VIV Asia, which runs from March 8-10, 2023, is the biggest feed to food event in Asia, bringing together world leaders in livestock production, feed production, animal farming, animal health solutions and all related sectors.


Company information

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.

About Nutrition & Care

The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.56 billion in 2021 with about 5,300 employees.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.